4//SEC Filing
PHARMATHENE, INC 4
Accession 0001144204-14-005265
$ALTCIK 0001326190operating
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:03 PM ET
Size
5.6 KB
Accession
0001144204-14-005265
Insider Transaction Report
Form 4
MORGES WAYNE
VP, Regulatory Affairs & Qual
Transactions
- Award
Stock Option (right to buy)
2014-01-29+190,000→ 190,000 totalExercise: $1.94Exp: 2024-01-29→ Common Stock (190,000 underlying)
Footnotes (2)
- [F1]The option vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.
- [F2]On January 29, 2014, the date such options were granted, the closing price of the Issuer's Common Stock on the NYSE Amex was $1.94 per share.
Documents
Issuer
PHARMATHENE, INC
CIK 0001326190
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001326190
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:03 PM ET
- Size
- 5.6 KB